Medication Adherence in Type 2 Diabetes Mellitus: Real-World Strategies for Addressing a Common Problem

被引：0
|
作者：
Brunton, Stephen A. [1 ,2 ]
Polonsky, William H. [3 ,4 ]
机构：
[1] Roseman Univ, Dept Clin Pharm Practice, Salt Lake City, UT 84101 USA
[2] Primary Care Educ Consortium, Educ, Los Angeles, CA 90017 USA
[3] Behav Diabet Inst, San Diego, CA 92121 USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
JOURNAL OF FAMILY PRACTICE | 2017年 / 66卷 / 04期
关键词：
FIXED-DOSE COMBINATION; PSYCHOLOGICAL INSULIN-RESISTANCE; HYPOGLYCEMIA FEAR SURVEY; TO-TARGET TRIAL; QUALITY-OF-LIFE; GLYCEMIC CONTROL; ECONOMIC OUTCOMES; DISPOSABLE PEN; BASAL INSULIN; WEIGHT-LOSS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S46 / S51
页数：6
相关论文
共 50 条
  • [21] Impact of personalized text messages from pharmacists on medication adherence in type 2 diabetes in France: A real-world, randomized, comparative study
    Gautier, Jean-Francois
    Boitard, Christian
    Michiels, Yves
    Raymond, Gerard
    Vergez, Geoffroy
    Guedon, Gersende
    PATIENT EDUCATION AND COUNSELING, 2021, 104 (09) : 2250 - 2258
  • [22] Real-World Adherence in Patients Aged=65 years with Type 2 Diabetes Mellitus for Exenatide QW, Liraglutide QD, and Exenatide BID
    Dufour, Robert
    Nguyen, Hiep
    Tarr, Amanda
    Bullano, Michael
    DIABETES, 2015, 64 : A294 - A295
  • [23] Addressing the Real-world Class Imbalance Problem in Dermatology
    Weng, Wei-Hung
    Deaton, Jonathan
    Natarajan, Vivek
    Elsayed, Gamaleldin F.
    Liu, Yuan
    MACHINE LEARNING FOR HEALTH, VOL 136, 2020, 136 : 415 - 432
  • [24] Introduction: Real-World Evidence in Type 2 Diabetes
    Hassanein, Mohamed
    Amod, Aslam
    Khunti, Kamlesh
    Lee, Moon-Kyu
    Mohan, Viswanathan
    DIABETES THERAPY, 2020, 11 (SUPPL 2) : S29 - S32
  • [25] Introduction: Real-World Evidence in Type 2 Diabetes
    Mohamed Hassanein
    Aslam Amod
    Kamlesh Khunti
    Moon-Kyu Lee
    Viswanathan Mohan
    Diabetes Therapy, 2020, 11 : 29 - 32
  • [26] Real-World Effectiveness of Sitagliptin as Add-On Therapy in Patients With Type 2 Diabetes Mellitus
    Chen, Tse-Ying
    Hsieh, Ching-Jung
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 205 - 215
  • [27] Review of real-world evidence studies in type 2 diabetes mellitus: Lack of good practices
    Lambert-Obry, Veronique
    Lafrance, Jean-Philippe
    Savoie, Michelle
    Henri, Sandrine
    Lachaine, Jean
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (04) : 372 - 379
  • [28] TYPE 2 DIABETES MELLITUS: LACK OF GOOD PRACTICES FOR REAL-WORLD EVIDENCE STUDIES.
    Lambert-Obry, V
    Lafrance, J.
    Savoie, M.
    Lachaine, J.
    VALUE IN HEALTH, 2018, 21 : S389 - S389
  • [29] Real-World Demographics and Clinical Characteristics of Type 2 Diabetes Mellitus Patients in Ontario, Canada
    Houlden, Robyn L.
    Golden, Shane
    Shi, Wei Zhe
    Kukaswadia, Atif A.
    Sharma, Arushi
    Quansah, Kobina
    Liu, Aiden R.
    DIABETES, 2022, 71
  • [30] Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis
    Buysman, Erin K.
    Chow, Wing
    Henk, Henry J.
    Rupnow, Marcia F. T.
    BMC ENDOCRINE DISORDERS, 2015, 15
12345